Retension Pharmaceuticals Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RTSN and other ETFs, options, and stocks.About RTSN
Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the development and severity of hypertension.
RTSN Key Statistics
Stock Snapshot
The current Retension Pharmaceuticals Inc.(RTSN) stock price is $10.04, with a market capitalization of 86.78M.
On 2026-10-10, Retension Pharmaceuticals Inc.(RTSN) stock traded between a low of $9.66 and a high of $11.60. Shares are currently priced at $10.04, which is +3.9% above the low and -13.5% below the high.
Retension Pharmaceuticals Inc.(RTSN) shares are trading with a volume of 789.08K, against a daily average of 789.21K.
In the last year, Retension Pharmaceuticals Inc.(RTSN) shares hit a 52-week high of $12.00 and a 52-week low of $9.66.
In the last year, Retension Pharmaceuticals Inc.(RTSN) shares hit a 52-week high of $12.00 and a 52-week low of $9.66.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.